Germano Geno J
CIK 0001424383
Director
Filings
17
Latest May 22, 2026
Issuers covered
4
Showing
17 of 17
Page 1
Track record
5 of 5 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 40% | -3.4% | -9.0% | +15.3% | -19.1% |
| 90 days | 4 | 50% | +3.1% | +0.5% | +30.7% | -19.3% |
| 180 days | 2 | 0% | -3.0% | -3.0% | -1.4% | -4.5% |
| 365 days | 2 | 100% | +15.4% | +15.4% | +27.1% | +3.8% |
Issuers
Companies where Germano Geno J has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| DTIL | Precision Biosciences Inc | 9 | May 22, 2026 |
| SAGE | Sage Therapeutics, Inc. | 5 | Jul 31, 2025 |
| ENTX | Entera Bio Ltd. | 2 | Mar 11, 2026 |
| HRMY | Harmony Biosciences Holdings, Inc. | 1 | May 18, 2026 |
All filings
17 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|